Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Arginase catalyzes the hydrolysis of arginine to ornithine and urea. Additionally we are shipping Arginase, Liver Kits (32) and Arginase, Liver Proteins (22) and many more products for this protein.
Showing 10 out of 228 products:
Fly (Calliphora) Monoclonal ARG1 Primary Antibody for IF, IP - ABIN968127
Chang, Zoghi, Liao, Kuo: The involvement of tyrosine kinases, cyclic AMP/protein kinase A, and p38 mitogen-activated protein kinase in IL-13-mediated arginase I induction in macrophages: its implications in IL-13-inhibited nitric oxide production. in Journal of immunology (Baltimore, Md. : 1950) 2000
Show all 5 references for ABIN968127
Mouse (Murine) Polyclonal ARG1 Primary Antibody for WB - ABIN374812
Sherman, Gutman, Chapnik, Meylan, le Coutre, Froy: All-trans retinoic acid modifies the expression of clock and disease marker genes. in The Journal of nutritional biochemistry 2012
Show all 2 references for ABIN374812
Dog (Canine) Polyclonal ARG1 Primary Antibody for WB - ABIN375082
Malerba, Pignatti: A review of asthma genetics: gene expression studies and recent candidates. in Journal of applied genetics 2005
Dog (Canine) Polyclonal ARG1 Primary Antibody for WB - ABIN374811
Zhang, Jia, Liu, Yang, Jiang, Tang, Li, Huang, Ma, Shen, Ye, Huang: Depletion of regulatory T cells facilitates growth of established tumors: a mechanism involving the regulation of myeloid-derived suppressor cells by lipoxin A4. in Journal of immunology (Baltimore, Md. : 1950) 2010
Human Polyclonal ARG1 Primary Antibody for IF (p), IHC (p) - ABIN1386869
Ma, Liu, Wang, Liu, Chen, Valle, Zuo, Xia, Liu: Crucial Role of Lateral Size for Graphene Oxide in Activating Macrophages and Stimulating Pro-inflammatory Responses in Cells and Animals. in ACS nano 2015
Human Polyclonal ARG1 Primary Antibody for FACS, IHC (p) - ABIN652925
Haraguchi, Aparicio, Takiguchi, Akaboshi, Yoshino, Mori, Matsuda: Molecular basis of argininemia. Identification of two discrete frame-shift deletions in the liver-type arginase gene. in The Journal of clinical investigation 1990
Human Polyclonal ARG1 Primary Antibody for ELISA, WB - ABIN190829
Jiang, Ding, Su, Hu, Li, Zhang: Arginase-flotillin interaction brings arginase to red blood cell membrane. in FEBS letters 2006
Cow (Bovine) Polyclonal ARG1 Primary Antibody for IHC, WB - ABIN2773866
Orellana, López, Uribe, Fuentes, Salas, Carvajal: Insights into the interaction of human liver arginase with tightly and weakly bound manganese ions by chemical modification and site-directed mutagenesis studies. in Archives of biochemistry and biophysics 2002
Cow (Bovine) Polyclonal ARG1 Primary Antibody for IHC, WB - ABIN2782309
Kitowska, Zakrzewicz, Königshoff, Chrobak, Grimminger, Seeger, Bulau, Eickelberg: Functional role and species-specific contribution of arginases in pulmonary fibrosis. in American journal of physiology. Lung cellular and molecular physiology 2008
These results showed that alterations in the expression levels of Arg I and iNOS (show NOS2 Antibodies) in the peripheral T cells and peripheral nodes of HIV infected patients are associated with disease progression in these patients.
Increased ARG1 expression in macrophages after a single radiotherapy dose is an independent prognostic factor of skin toxicities.
Arginase inhibition arrests human pulmonary artery smooth muscle cells in the G1/G0-phase under hypoxic conditions.
Arginase from neutrophils can modulate nitric oxide production from activated macrophages which may affect the course of infection by intracellular bacteria.
Overexpression and elevated activity of arginase I are involved in tobacco-induced pulmonary endothelial dysfunction.
This method not only solved the problem of obtaining a large amount of arginase, but also provided a promising alternative for the future industrial production of L-Orn.
the combination of high levels of CD14 (show NDUFA2 Antibodies), FOXP3 (show FOXP3 Antibodies), and ARG1 mRNAs identified a small group of patients with excellent event-free and overall survival.
Overexpression of Arg1 in the CNS of transgenic mice significantly reduced tau pathology.
data indicate that helminth coinfection induces arginase-1-expressing type 2 granulomas, thereby increasing inflammation and TB disease severity.
The data exclude a prognostic role of IL-10 (show IL10 Antibodies) and ARG-1 in metastatic neuroblastoma (show ARHGEF16 Antibodies).
Arginase has a role in preventing angiogenesis in endothelial cells exposed to hypoxia
Ang II (show AGT Antibodies) increases endothelial arginase activity/expression through a p38 MAPK (show MAPK14 Antibodies)/ATF-2 (show ATF2 Antibodies) pathway leading to reduced endothelial NO production
results indicate that arginase induction depends in part on epidermal growth factor (EGF (show EGF Antibodies)) receptor (show EGFR Antibodies) activity, and that EGFR (show EGFR Antibodies) inhibitors may attenuate vascular remodeling without affecting nitric oxide release
high glucose (HG)-treated bovine coronary endothelial cells (BCECs) showed increased arginase activity and diminished NO production
Results show that arginase 1 is abundantly present in the bone and bone marrow stromal cells and reveal the role of its deregulation in diabetes-induced bone complications. * HFHS diet induced Arginase activity and expression in bone and bone marrow.
T Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 (show ENTPD1 Antibodies) but Not Arginase-1.
The production of arginase-1 by tumor cells leads to an ineffective anti-tumor immune response.
Arg1+ microglia are involved in Abeta (show APP Antibodies) plaque reduction during sustained, IL-1beta (show IL1B Antibodies)-dependent neuroinflammation
findings suggest that increased IL-17A (show IL17A Antibodies) expression by macrophages in E7-expressing skin exposed to DNCB promotes arginase-1 induction and contributes directly to the observed hyperinflammation.
Arginase 1 is crucially involved in Ang II (show AGT Antibodies)-induced smooth muscle cell proliferation and arterial fibrosis and stiffness and represents a promising therapeutic target.
FoxO4 (show FOXO4 Antibodies) activates Arg1 transcription in endothelial cells in response to MI, leading to downregulation of nitric oxide and upregulation of neutrophil infiltration to the infarct area.
TAT (show TAT Antibodies) fused to WW2/WW3 of Smurf2 (show SMURF2 Antibodies) could interfere with TGF-beta (show TGFB1 Antibodies) signaling and reduce ArgI gene expression.
ARG1 activity may participate in the pathogenesis of lymphoproliferative and myeloproliferative disorders.
The immunosuppressive effect of a purified substance (ISF (show ATP6V0A2 Antibodies)) in the culture medium of neonatal pig liver fragments was due to arginase activity that decreased arginine concentration in culture medium, not to another function of ISF (show ATP6V0A2 Antibodies).
Results show that ischemia markedly potentiated the expression of arginase-1, and also induced the SOD2 (show SOD2 Antibodies) in the wound tissue.
Arginase catalyzes the hydrolysis of arginine to ornithine and urea. At least two isoforms of mammalian arginase exist (types I and II) which differ in their tissue distribution, subcellular localization, immunologic crossreactivity and physiologic function. The type I isoform encoded by this gene, is a cytosolic enzyme and expressed predominantly in the liver as a component of the urea cycle. Inherited deficiency of this enzyme results in argininemia, an autosomal recessive disorder characterized by hyperammonemia. Two transcript variants encoding different isoforms have been found for this gene.
, liver-type arginase
, type I arginase
, arginase 1
, arginase I
, arginase 1, liver
, AI type I arginase
, arginase, hepatic